Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 291 followers
Latest posts
Last updated about 9 hours ago
New findings shed light on cause of Huntington's disease progression
about 9 hours ago
A new study of nerve cells affected by Huntington’s disease (HD) reveals...
FDA’s device chief calls for more authority to address supply chain shortages impacting pediatric, neonatal patients
about 13 hours ago
Shortages of appropriate devices may force clinicians to adapt with equipment for...
WuXi AppTec sells US medical device testing business to NAMSA
about 13 hours ago
The deal includes facilities in Atlanta, Georgia and St. Paul, Minnesota; the...
‘Own JP Morgan, don't let JP Morgan own you’: Biopharma—and Jill Biden—show up for JPM25
about 16 hours ago
This year’s JP Morgan struck a different tone than previous years—a very...
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
about 18 hours ago
One of the biggest stories of last year was Lykos Therapeutics’ failure...
Chutes & Ladders—Apellis COO stepping down to take first CEO job
about 18 hours ago
After six years at Apellis, Chief Operating Officer Adam Townsend is saying...
Notch begins 'significant' layoffs, blames tough environment for preclinical cell therapy biotechs
about 20 hours ago
Notch Therapeutics is making “significant” layoffs to conserve its cash while the...
Boehringer’s phase 3 schizophrenia program misses primary goal
1 day ago
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or...
Google Cloud 'can't wait to see what's next'as Servier extends AI drug R&D pact
1 day ago
Servier is extending its pact with Google Cloud as the French biopharma...
Avacta expands peptide-drug conjugate study after seeing 10% response rate
1 day ago
Avacta is stepping up development of its peptide-drug conjugate, kicking off expansion...
Serina sells AgeX assets to shareholder Juvenescence to become debt-free
2 days ago
Serina Therapeutics is shedding a subsidiary to start the new year off...
JPM25: GE HealthCare, UCSF launch research hub for cancer, neurodegenerative disease imaging
3 days ago
The project will launch a Care Innovation Hub within UCSF’s Department of...